Vitamin D Induces Interleukin-1β Expression: Paracrine Macrophage Epithelial Signaling Controls M. tuberculosis Infection

PLoS Pathogens

Volumn 9, Issue 6, 2013, Pages

  Verway, Mark ^a   Bouttier, Manuella ^a   Wang, Tian Tian ^a   Carrier, Marilyn ^a   Calderon, Mario ^a   An, Beum Soo ^a   Devemy, Emmanuelle ^b   McIntosh, Fiona ^c   Divangahi, Maziar ^a,b   Behr, Marcel A ^a   White, John H ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; SMALL INTERFERING RNA; TRANSCRIPTOME; VITAMIN D;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOREGULATION; LIMIT OF QUANTITATION; MACROPHAGE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TUBERCULOSIS; WESTERN BLOTTING;

ANIMALS; BETA-DEFENSINS; CALCITRIOL; CARRIER PROTEINS; CASPASE 1; CELL LINE; COCULTURE TECHNIQUES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1BETA; MACROPHAGES, PERITONEAL; MALE; MICE; MYCOBACTERIUM TUBERCULOSIS; PARACRINE COMMUNICATION; RECEPTORS, INTERLEUKIN-1 TYPE I; RESPIRATORY MUCOSA; TUBERCULOSIS; VITAMINS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84879511702     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003407     Document Type: Article

References (62)

1. Dye C, (2006) Global epidemiology of tuberculosis. The Lancet 367: 938-940.
2. Keeler E, Perkins MD, Small P, Hanson C, Reed S, et al. (2006) Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 444 Suppl 1: 49-57.
3. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, et al. (2000) Outcomes of contact investigations of infectious tuberculosis patients. American Journal of Respiratory and Critical Care Medicine 162: 2033-2038.
4. Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL, (2008) Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 8: 142-152.
5. Li Y, Wang Y, Liu X, (2012) The Role of Airway Epithelial Cells in Response to Mycobacteria Infection. Clinical and Developmental Immunology 2012: 11.
6. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, et al. (1998) Production of β-defensins by human airway epithelia. Proceedings of the National Academy of Sciences 95: 14961-14966.
7. Corrales-Garcia L, Ortiz E, Castañeda-Delgado J, Rivas-Santiago B, Corzo G, (2013) Bacterial expression and antibiotic activities of recombinant variants of human β-defensins on pathogenic bacteria and M. tuberculosis. Protein Expr Purif 89 (1): 33-43.
8. Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, et al. (2010) Cutting Edge: Caspase-1 Independent IL-1β Production Is Critical for Host Resistance to Mycobacterium tuberculosis and Does Not Require TLR Signaling In Vivo. The Journal of Immunology 184: 3326-3330.
9. Fremond CM, Togbe D, Doz E, Rose S, Vasseur V, et al. (2007) IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection. The Journal of Immunology 179: 1178-1189.
10. Juffermans NP, Florquin S, Camoglio L, Verbon A, Kolk AH, et al. (2000) Interleukin-1 Signaling Is Essential for Host Defense during Murine Pulmonary Tuberculosis. Journal of Infectious Diseases 182: 902-908.
11. Yamada H, Mizumo S, Horai R, Iwakura Y, Sugawara I, (2000) Protective Role of Interleukin-1 in Mycobacterial Infection in IL-1 α/β Double-Knockout Mice. Lab Invest 80: 759-767.
12. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, et al. (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458: 514-518.
13. Tsuchiya K, Hara H, Kawamura I, Nomura T, Yamamoto T, et al. (2010) Involvement of Absent in Melanoma 2 in Inflammasome Activation in Macrophages Infected with Listeria monocytogenes. J Immunol 185: 1186-1195.
14. Warren SE, Armstrong A, Hamilton MK, Mao DP, Leaf IA, et al. (2010) Cutting Edge: Cytosolic Bacterial DNA Activates the Inflammasome via Aim2. J Immunol 185: 818-821.
15. Fernandes-Alnemri T, Yu J-W, Juliana C, Solorzano L, Kang S, et al. (2010) The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 11: 385-393.
16. Rathinam VAK, Jiang Z, Waggoner SN, Sharma S, Cole LE, et al. (2010) The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 11: 395-402.
17. Coulombe F, Divangahi M, Veyrier F, de Leseleuc L, Gleason JL, et al. (2009) Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. The Journal of Experimental Medicine 206: 1709-1716.
18. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, et al. (2001) Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB. Journal of Biological Chemistry 276: 4812-4818.
19. Divangahi M, Mostowy S, Coulombe F, Kozak R, Guillot L, et al. (2008) NOD2-Deficient Mice Have Impaired Resistance to Mycobacterium tuberculosis Infection through Defective Innate and Adaptive Immunity. The Journal of Immunology 181: 7157-7165.
20. Hsu LC, Ali SR, McGillivray S, Tseng PH, Mariathasan S, et al. (2008) A NOD2-NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proceedings of the National Academy of Sciences 105: 7803-7808.
21. Yang CS, Shin DM, Jo EK, (2012) The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases. Int Neurourol J 16: 2-12.
22. Koo IC, Wang C, Raghavan S, Morisaki JH, Cox JS, et al. (2008) ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection. Cellular Microbiology 10: 1866-1878.
23. TeKippe EM, Allen IC, Hulseberg PD, Sullivan JT, McCann JR, et al. (2010) Granuloma Formation and Host Defense in Chronic Mycobacterium tuberculosis Infection Requires PYCARD/ASC but Not NLRP3 or Caspase-1. PLoS One 5: e12320.
24. Masten AR, (1935) Sunlight in Tuberculosis. Chest 1: 8-23.
25. White JH, (2008) Vitamin D Signaling, Infectious Diseases, and Regulation of Innate Immunity. Infect Immun 76: 3837-3843.
26. Chan TYK, (2000) Vitamin D Deficiency and Susceptibility to Tuberculosis. Calcified Tissue International 66: 476-478.
27. Davies PD, Brown RC, Woodhead JS, (1985) Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 40: 187-190.
28. Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn HJ, (2007) Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax 62: 1003-1007.
29. Nnoaham KE, Clarke A, (2008) Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. International Journal of Epidemiology 37: 113-119.
30. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, et al. (2004) Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression. J Immunol 173: 2909-2912.
31. Gombart A, Borregaard N, Koeffler H, (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 19: 1067-1077.
32. Wang TT, Dabbas B, Laperriere D, Bitton AJ, Soualhine H, et al. (2010) Direct and Indirect Induction by 1,25-Dihydroxyvitamin D3 of the NOD2/CARD15-Defensin β2 Innate Immune Pathway Defective in Crohn Disease. Journal of Biological Chemistry 285: 2227-2231.
33. White JH, (2012) Vitamin D metabolism and signaling in the immune system. Reviews in Endocrine & Metabolic Disorders 13: 21-29.
34. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response. Science 311: 1770-1773.
35. Szeles L, Keresztes G, Torocsik D, Balajthy Z, Krenacs L, et al. (2009) 1,25-Dihydroxyvitamin D(3) Is an Autonomous Regulator of the Transcriptional Changes Leading to a Tolerogenic Dendritic Cell Phenotype. Journal of Immunology 182: 2074-2083.
36. Kisich KO, Heifets L, Higgins M, Diamond G, (2001) Antimycobacterial Agent Based on mRNA Encoding Human β-Defensin 2 Enables Primary Macrophages To Restrict Growth ofMycobacterium tuberculosis. Infection and Immunity 69: 2692-2699.
37. Martineau AR, Newton SM, Wilkinson KA, Kampmann B, Hall BM, et al. (2007) Neutrophil-mediated innate immune resistance to mycobacteria. The Journal of Clinical Investigation 117: 1988-1994.
38. Campbell GR, Spector SA, (2012) Vitamin D Inhibits Human Immunodeficiency Virus Type 1 and Mycobacterium tuberculosis Infection in Macrophages through the Induction of Autophagy. PLoS Pathog 8: e1002689.
39. Liu P, Stenger S, Tang D, Modlin R, (2007) Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 179: 2060-2063.
40. Master SS, Rampini SK, Davis AS, Keller C, Ehlers S, et al. (2008) Mycobacterium tuberculosis Prevents Inflammasome Activation. Cell Host & Microbe 3: 224-232.
41. Cooper AM, Mayer-Barber KD, Sher A, (2011) Role of innate cytokines in mycobacterial infection. Mucosal Immunol 4: 252-260.
42. Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, Burton MacLeod N, et al. (2005) Large-Scale in Silico and Microarray-Based Identification of Direct 1,25-Dihydroxyvitamin D3 Target Genes. Mol Endocrinol 19: 2685-2695.
43. Zella LA, Kim S, Shevde NK, Pike JW, (2006) Enhancers Located within Two Introns of the Vitamin D Receptor Gene Mediate Transcriptional Autoregulation by 1,25-Dihydroxyvitamin D3. Mol Endocrinol 20: 1231-1247.
44. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. (2002) The Human Genome Browser at UCSC. Genome Research 12: 996-1006.
45. Gupta UD, Katoch VM, (2005) Animal models of tuberculosis. Tuberculosis 85: 277-293.
46. Lamkanfi M, (2011) Emerging inflammasome effector mechanisms. Nat Rev Immunol 11: 213-220.
47. Bryan NB, Dorfleutner A, Rojanasakul Y, Stehlik C, (2009) Activation of Inflammasomes Requires Intracellular Redistribution of the Apoptotic Speck-Like Protein Containing a Caspase Recruitment Domain. The Journal of Immunology 182: 3173-3182.
48. Matsushita K, Takeoka M, Sagara J, Itano N, Kurose Y, et al. (2009) A Splice Variant of ASC Regulates IL-1β Release and Aggregates Differently from Intact ASC. Mediators of Inflammation 2009.
49. Schroder K, Tschopp J, (2010) The Inflammasomes. Cell 140: 821-832.
50. TeKippe EM, Allen IC, Hulseberg PD, Sullivan JT, McCann JR, et al. (2010) Granuloma Formation and Host Defense in Chronic Mycobacterium tuberculosis Infection Requires PYCARD/ASC but Not NLRP3 or Caspase-1. PLoS One 5: e12320.
51. Brooks MN, Rajaram MVS, Azad AK, Amer AO, Valdivia-Arenas MA, et al. (2011) NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages. Cellular Microbiology 13: 402-418.
52. Thompson A, Robbins R, Romberger D, Sisson J, Spurzem, et al. (1995) Immunological functions of the pulmonary epithelium. European Respiratory Journal 8: 127-149.
53. Liu PT, Schenk M, Walker VP, Dempsey PW, Kanchanapoomi M, et al. (2009) Convergence of IL-1β and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses. PLoS ONE 4: e5810.
54. Xia Y, Zhai Q, (2010) IL-1β enhances the antibacterial activity of astrocytes by activation of NF-κB. Glia 58: 244-252.
55. Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, et al. (2009) Vitamin D3 Induces Autophagy in Human Monocytes/Macrophages via Cathelicidin. Cell Host Microbe 6: 231-243.
56. Ippagunta SK, Malireddi RKS, Shaw PJ, Neale GA, Walle LV, et al. (2011) The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization. Nat Immunol 12: 1010-1016.
57. Kolls JK, McCray PB, Chan YR, (2008) Cytokine-mediated regulation of antimicrobial proteins. Nat Rev Immunol 8: 829-835.
58. Abreu MT, (2010) Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10: 131-144.
59. Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ, (2007) Vitamin D in the treatment of pulmonary tuberculosis. The Journal of Steroid Biochemistry and Molecular Biology 103: 793-798.
60. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, et al. (2011) High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. The Lancet 377: 242-250.
61. Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, et al. (2012) Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proceedings of the National Academy of Sciences 109: 15449-15454.
62. Calderon MR, Verway M, An B-S, DiFeo A, Bismar TA, et al. (2012) Ligand-dependent Corepressor (LCoR) Recruitment by Krüppel-like Factor 6 (KLF6) Regulates Expression of the Cyclin-dependent Kinase Inhibitor CDKN1A Gene. Journal of Biological Chemistry 287: 8662-8674.